2024-02-05 18:08:00 Pharmaceutical giant Novo Nordisk NOVO NORDISK A/S +3.54% Close:0 Open:116.39 High:118.32 Low:116.27 Turnover:– Page …
Tag:
Novo Nordisk A/S
- Business
Pfizer stops development of twice-daily experimental weight loss pill but still plans to release once-a-day version trial data in 2024
by time newsby time newsPfizer Halts Development of Twice-Daily Weight Loss Pill Due to Tolerance Issues Pfizer announced on Friday …